Cite
HARVARD Citation
Frishberg, Y. et al. (2021). Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1. Clinical journal of the American Society of Nephrology. 16 (7), pp. 1025-1036. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Frishberg, Y. et al. (2021). Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1. Clinical journal of the American Society of Nephrology. 16 (7), pp. 1025-1036. [Online].